Navigation Links
K-State Researchers Predict That an Outbreak of Foot-And-Mouth Disease Could Cost Kansas Nearly a Billion Dollars
Date:11/27/2007

MANHATTAN, Kan., Nov. 27 /PRNewswire-USNewswire/ -- As much as $945 million. That's what agricultural economists at Kansas State University say could be the impact on Kansas' economy were there a large-scale foot-and-mouth outbreak in a region thick with livestock operations.

"If such an outbreak were to occur, livestock and meat commerce, trade, and movement would be halted," said Ted Schroeder, a K-State professor of agricultural economics. "That represents a very, very expensive endeavor."

Schroeder is co-author of a paper that predicts a devastating economic impact should foot-and-mouth disease come to Kansas.

The paper, based on the dissertation of K-State agricultural economics doctoral graduate Dustin Pendell, now on the faculty at Colorado State University, was also co-authored by John Leatherman, professor of agricultural economics at K-State. The group's paper was recently published in a special October edition of the Journal of Agricultural and Applied Economics.

Foot-and-mouth disease is a highly contagious viral disease that does not affect humans, but can have devastating effects on cloven-hoofed animals such as cattle, swine, sheep, goats and deer. The United States has not had case of foot-and-mouth disease since 1929.

The team of K-State researchers analyzed a 14-county region in southwest Kansas that has a high concentration of large cattle feeding operations, as well as other livestock enterprises and beef processing plants. They considered three scenarios: one where the disease was introduced at a single cow-calf operation; one where a medium-sized feedlot, 10,000 to 20,000 head of cattle, was initially infected; and one where five large feedlots, each with more than 40,000 head of

cattle, were simultaneously exposed. Schroeder said the first two scenarios were used to predict what could happen if the disease were introduced accidentally, while the larger scenario shows what could happen
'/>"/>

SOURCE Kansas State University
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Expert on Emerging Infectious Zoonotic Diseases Joining K-State as a Regents Distinguished Professor
2. Professionals in bioscience, food-related industries turn to K-State
3. K-State Veterinary Lab Routinely Tests For Bluetongue Virus; Lab Director Says Strains Found in Kansas, U.S. Usually Less-Virulent
4. Stanford researchers find culprit in aging muscles that heal poorly
5. UCLA researchers identify markers that may predict diabetes in still-healthy people
6. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
7. Bipolar disorder relapses halved by Melbourne researchers
8. Cell that triggers symptoms in allergy attacks can also limit damage, Stanford researchers find
9. High and mighty: first common height gene identified by researchers behind obesity gene finding
10. Researchers estimate about 9 percent of US children age 8 to 15 meet criteria for having ADHD
11. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...Pa., Nov. 21 During a ... Edward G. Rendell today remembered Lieutenant Gov... an important partner in public service, and a tir... , "As the first woman elected lieutenant gov...rvant," said Governor Rendell. "Her family and her...
(Date:11/21/2008)...ers remain cautious about future antibiotic resist...ov. 21 (HealthDay News) -- People with moderate to...D) may be able to reduce the frequency of exacerba...biotic, a new report says. , The study, publis...an Journal of Respiratory and Critical Care Medici...
(Date:11/21/2008)...W.Va., Nov. 21 New rese...ether a smokeless, spitless tobacco product aimed ...s have found that RJ Reynolds, Camel Snus - touted... - contains surprisingly high levels of nicotine. ... most other snuff products," said Bruce Adkins of ...
(Date:11/21/2008)...v. 21 The general membership of th...t three new individuals at their Annual,Awards Di...tel in New York. A,Lifetime Achievement Award wil...the Medical Advertising Hall of Fame are: , Ron...h an account position,at Sudler & Hennessey. ...
Breaking Medicine News(10 mins):Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 2Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 3Health News:Long-Term Erythromycin Cut COPD Complications 2Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 2Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 3
...ay provide long-term protection against the incide...d breathing disorder). The study, conducted by Ha...iversity, focused on the parents of those children...aphy, who filled out a brief survey about whether ...
...thank you, we can do it on our own, Australians se...alian shoppers are turning to supermarket shelves ...,000 of them, which measure blood sugar levels, ha... months. Diabetes is the country's fastest-growi...
...alright. But there is a flip side too . Swimming ...ld's risk of developing asthma. The traditional ad...ics could be off the mark, a new study seems to in...ng journal, reported last week that children who s...
...cs, reading, and writing better watch out for symp...rch suggests that such symptoms may cause students...rs. Authored by Alyssa Bachmann of Chappaqua Publi...he parents of 218 second and third graders, who co...
Other Medicine News:Health News:Breast-feeding may Protect Against Childhood Sleep-related Breathing Disorder 2Health News:Australians Opt for DIY Kits to Test for Diabetes 2Health News:Exposure to Chlorinated Swimming Pools Could Increase Asthma Risk in Children 2Health News:Students With Sleep Disorder Symptoms Score Badly in Maths 2
(Date:11/20/2008)...Newswire/ -- Radius Health ("Radius") announced to...o its second institutional financing round, increa...d the total amount raised since the company,s ince...l investors participated in the financing, led by ...pital, The Wellcome Trust, HealthCare Ventures, Ox...
(Date:11/19/2008)...9 Amgen,(Nasdaq: AMGN...subsidiary of,Takeda Pharmaceutical Company Limit...n the Phase 3 MONET1 trial evaluating motesanib (A...latin for the first-line treatment of,advanced no...ily suspended,following a planned safety data rev...
(Date:11/19/2008)...from Roche- , , MONTVALE, N.J., Nov. 19 /PR.... (Nasdaq: MEMY ) today announced that it has ac...f R3487/MEM 3454, its lead alpha-7 nicotinic recep...th schizophrenia (CIAS). The Company has randomiz... $5.0 million payment from its partner Roche. Mem...
(Date:11/18/2008)...008 Faces of Influenza survey underscores that mot...nza; Mother and Gold Medalist Kristi Yamaguchi joi...ewswire/ -- While 78 percent of mothers in the Uni...ally life-threatening disease that can strike anyo... get vaccinated this season, according to a new su...
Breaking Medicine Technology:Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 2Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 4Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 5Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 6Dense tissue promotes aggressive cancers 4581 1Dense tissue promotes aggressive cancers 4581 2Vermillion Announces Publication of Data Supporting Its Peripheral Artery Disease Diagnostic Test Program 25689 1Vermillion Announces Publication of Data Supporting Its Peripheral Artery Disease Diagnostic Test Program 25689 2Vermillion Announces Publication of Data Supporting Its Peripheral Artery Disease Diagnostic Test Program 25689 3RMA of Michigan Hosts 1st Metro Detroit Area Hope Uncorked 3A Exclusive Wine Tasting Event To Benefit Fertile Hope 25687 1RMA of Michigan Hosts 1st Metro Detroit Area Hope Uncorked 3A Exclusive Wine Tasting Event To Benefit Fertile Hope 25687 2The challenge of paying for quality nursing care 25685 1The challenge of paying for quality nursing care 25685 2
...nix Medical,Corporation (OTC BB: CONX) and the Com...l data demonstrating a significant correlation,bet...x(TM),bio-markers and cardiovascular disease. The ...ternational Society on Thrombosis and,Hemostasis (...week shows the association of antibodies to,the At...
... Portola,Pharmaceuticals, Inc. announced positive ...oral Factor Xa inhibitor, today at the XXI,Congres...aemostasis,(ISTH) in Geneva, Switzerland. The EXPE..., and well tolerated for the,prevention of venous ... total knee replacement (TKR) surgery. Portola exp...
Other Medicine Technology:Corgenix Reports New Clinical Data Correlating AtherOx Technology,With Vascular Disease 2Corgenix Reports New Clinical Data Correlating AtherOx Technology,With Vascular Disease 3Corgenix Reports New Clinical Data Correlating AtherOx Technology,With Vascular Disease 4Portola Pharmaceuticals Announces Positive Data from a Phase II,Study of its Factor Xa Inhibitor at the XXI Congress of the,International Society on Thrombosis and Haemostasis 2Portola Pharmaceuticals Announces Positive Data from a Phase II,Study of its Factor Xa Inhibitor at the XXI Congress of the,International Society on Thrombosis and Haemostasis 3Portola Pharmaceuticals Announces Positive Data from a Phase II,Study of its Factor Xa Inhibitor at the XXI Congress of the,International Society on Thrombosis and Haemostasis 4
Keeler Professional Combi Retinoscope with new slimline handle and lithium or dry cell option.
300XL System, English (U.K. cord), 100-240 VAC.
Micro-mini fiber optic light.
Xenon technology achieves a higher efficiency than halogen light sources. Consequently they provide more light.
Medicine Products: